Cell Cycle Arrest Induced by the Vitamin D3 Analog EB1089 in NCI-H929 Myeloma Cells Is Associated with Induction of the Cyclin-Dependent Kinase Inhibitor p27
- 1 February 2000
- journal article
- Published by Elsevier BV in Experimental Cell Research
- Vol. 254 (2), 279-286
- https://doi.org/10.1006/excr.1999.4735
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Vitamin D3 analogs and their 24-Oxo metabolites equally inhibit clonal proliferation of a variety of cancer cells but have differing molecular effectsJournal of Cellular Biochemistry, 1997
- Actions of vitamin D3, analogs on human prostate cancer cell lines: comparison with 1,25-dihydroxyvitamin D3.Endocrinology, 1995
- Use of Vitamins A and D in Chemoprevention and Therapy of Cancer: Control of Nuclear Receptor Expression and FunctionAdvances in experimental medicine and biology, 1995
- Effects of synthetic vitamin d analogues on breast cancer cell proliferation in vivo and in vitroBiochemical Pharmacology, 1992
- Topical calcipotriol treatment in advanced breast cancerThe Lancet, 1991
- The Role of the Vitamin D Endocrine System in Health and DiseaseNew England Journal of Medicine, 1989
- In vitro study of effects of 1,25 dihydroxyvitamin D3 on the morphology of human breast cancer cell line BT.20Differentiation, 1989
- 1,25(OH) 2 ‐Vitamin D 3 receptors: gene regulation and genetic circuitryThe FASEB Journal, 1988
- 1,25-Dihydroxyvitamin D 3 Receptors in Human LeukocytesScience, 1983
- 1,25-DIHYDROXYVITAMIN-D RECEPTOR IN BREAST CANCER CELLSThe Lancet, 1979